Joel Kramer Selected Research

Joel Kramer Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 11/2012
13	Cognitive Dysfunction 03/2024 - 11/2005
9	Dementia (Dementias) 04/2024 - 01/2018
4	Frontotemporal Dementia (Semantic Dementia) 10/2022 - 10/2018
3	Disease Progression 03/2024 - 10/2018
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2024 - 01/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 11/2005
2	Amyloid Plaque 05/2021 - 04/2015
2	Stroke (Strokes) 01/2021 - 11/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 03/2013
1	Atrophy 11/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Brain Diseases (Brain Disorder) 12/2022
1	Cerebral Small Vessel Diseases 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Contusions 01/2021
1	Hematoma 01/2021
1	Subdural Hematoma (Subdural Hemorrhage) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Primary Progressive Aphasia 10/2018
1	Craniocerebral Trauma (Head Injury) 01/2018
1	Brain Concussion (Cerebral Concussion) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Memory Disorders (Memory Loss) 01/2018
1	Autoimmune limbic encephalitis 10/2015
1	Tauopathies 04/2015
1	Corticobasal Degeneration 01/2015
1	Myocardial Infarction 11/2012
1	Infarction (Infarctions) 11/2012
1	Brain Infarction 11/2012
1	Breast Neoplasms (Breast Cancer) 12/2008
1	Fatigue 12/2008

Drug/Important Bio-Agent (IBA)

15	Amyloid (Amyloid Fibrils)IBA 03/2024 - 01/2015
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2018
4	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2021
2	ApolipoproteinsIBA 11/2023 - 11/2012
2	Apolipoproteins E (ApoE)IBA 11/2023 - 11/2023
2	Amyloid beta-PeptidesIBA 11/2023 - 12/2021
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 12/2008
1	TESIBA 04/2024
1	Cerebrospinal Fluid ProteinsIBA 03/2024
1	ProteomeIBA 03/2024
1	tau Proteins (tau Protein)IBA 03/2024
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	Chemokine CCL11IBA 12/2022
1	Chemotactic FactorsIBA 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2022
1	Placenta Growth FactorIBA 12/2022
1	Presenilin-1IBA 01/2022
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 07/2021
1	complexin IIIBA 05/2021
1	complexin IIBA 05/2021
1	CholesterolIBA 01/2021
1	CreatinineIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	ProgranulinsIBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 10/2015
1	AntibodiesIBA 10/2015
1	adenylate kinase 5IBA 10/2015
1	AutoantibodiesIBA 10/2015
1	AD 5IBA 01/2015
1	Antidepressive Agents (Antidepressants)IBA 07/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2008 - 11/2005
2	Therapeutics 01/2023 - 03/2013
1	Nephrectomy 01/2023
1	Aftercare (After-Treatment) 01/2018
1	Immunotherapy 10/2015